Sanofi Aventis
Strategic Management Report (Spring 2012) MAN405F
Submitted To: Sir Abdul Qadir Molvi
Submitted By:
Mehmood Shekhani
Contents objectives 4 INtroduction to sanofi Sanofi pakistan 5 Vision STATEMNT 6 Mission STATEMENT 6 ANALYSIS OF THE INDUSTRY USING MICHAEL PORTER’S FIVE COMPETITIVE FORCES 13 External Factor Evaluation 19 Competitive Profile Matrix (C.P.M) 21 Financial Trends 22 Interpretation 26 Value Chain Analysis 29 Support activities 32 Core Competencies 34 Strategic Cost Management Process 36 Internal Factor Evaluation 37 TOWS Matrix 40 Grand Strategy Matrix 42 Internal External (IE) Matrix 43 The QSPM Matrix 44
Executive Summary
This report focuses of the strategic analysis of the performance of Sanofi.
Sanofi a global name in the pharmaceutical industry holds the 5th position in the Pharmaceutical industry of Pakistan. Sanofi Sanofi works on seven major therapeutic areas; namely: Cardiovascular, Thrombosis, Oncology, Central Nervous System, Metabolic Disorders, Internal Medicine and Vaccines.
The report involves understanding of external environmental factors and its impact on the business. The study will look into the strength and weakness of the company in relation to external environment to determine competitive strategic position.
It analyzes the current strategy of Sanofi and investigates its short comings. Corrective action and future strategy for Sanofi is also recommended based on its competitive position in the market and its internal activities.
The tools used for external environment and industry analysis includes pest analysis, porters 5 force model, SWOT analysis, tows matrix, external factor evaluation, competitive position matrix.
The tools used for analysis of internal environment include internal factor evaluation, SPACE matrix, and value chain analysis.
Furthermore we have used grand strategy matrix, IE matrix, QSPM to formulate the strategic options for Sanofi.
objectives
*
Submitted To: Sir Abdul Qadir Molvi
Submitted By:
Mehmood Shekhani
Contents objectives 4 INtroduction to sanofi Sanofi pakistan 5 Vision STATEMNT 6 Mission STATEMENT 6 ANALYSIS OF THE INDUSTRY USING MICHAEL PORTER’S FIVE COMPETITIVE FORCES 13 External Factor Evaluation 19 Competitive Profile Matrix (C.P.M) 21 Financial Trends 22 Interpretation 26 Value Chain Analysis 29 Support activities 32 Core Competencies 34 Strategic Cost Management Process 36 Internal Factor Evaluation 37 TOWS Matrix 40 Grand Strategy Matrix 42 Internal External (IE) Matrix 43 The QSPM Matrix 44
Executive Summary
This report focuses of the strategic analysis of the performance of Sanofi.
Sanofi a global name in the pharmaceutical industry holds the 5th position in the Pharmaceutical industry of Pakistan. Sanofi Sanofi works on seven major therapeutic areas; namely: Cardiovascular, Thrombosis, Oncology, Central Nervous System, Metabolic Disorders, Internal Medicine and Vaccines.
The report involves understanding of external environmental factors and its impact on the business. The study will look into the strength and weakness of the company in relation to external environment to determine competitive strategic position.
It analyzes the current strategy of Sanofi and investigates its short comings. Corrective action and future strategy for Sanofi is also recommended based on its competitive position in the market and its internal activities.
The tools used for external environment and industry analysis includes pest analysis, porters 5 force model, SWOT analysis, tows matrix, external factor evaluation, competitive position matrix.
The tools used for analysis of internal environment include internal factor evaluation, SPACE matrix, and value chain analysis.
Furthermore we have used grand strategy matrix, IE matrix, QSPM to formulate the strategic options for Sanofi.
objectives
*
Bibliography: http://www.pharmaceutical-business-review.com/ http://www.sanofi-Sanofi.com.pk/ Annual Report of Sanofi 2011 http://en.wikipedia.org/wiki/Sanofi